Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd

SZSE:301130 Stock Report

Market Cap: CN¥2.0b

Jilin Province Xidian Pharmaceutical Sci-Tech DevelopmentLtd Dividends and Buybacks

Dividend criteria checks 2/6

Jilin Province Xidian Pharmaceutical Sci-Tech DevelopmentLtd is a dividend paying company with a current yield of 0.99% that is well covered by earnings.

Key information

1.0%

Dividend yield

4.6%

Buyback Yield

Total Shareholder Yield5.6%
Future Dividend Yieldn/a
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per shareCN¥0.260
Payout ratio47%

Recent dividend and buyback updates

Jilin Province Xidian Pharmaceutical Sci-Tech DevelopmentLtd (SZSE:301130) Is Increasing Its Dividend To CN¥0.26

Jun 07
Jilin Province Xidian Pharmaceutical Sci-Tech DevelopmentLtd (SZSE:301130) Is Increasing Its Dividend To CN¥0.26

Recent updates

Jilin Province Xidian Pharmaceutical Sci-Tech DevelopmentLtd's (SZSE:301130) Weak Earnings Might Be Worse Than They Appear

Nov 02
Jilin Province Xidian Pharmaceutical Sci-Tech DevelopmentLtd's (SZSE:301130) Weak Earnings Might Be Worse Than They Appear

Jilin Province Xidian Pharmaceutical Sci-Tech DevelopmentLtd (SZSE:301130) Is Increasing Its Dividend To CN¥0.26

Jun 07
Jilin Province Xidian Pharmaceutical Sci-Tech DevelopmentLtd (SZSE:301130) Is Increasing Its Dividend To CN¥0.26

Jilin Province Xidian Pharmaceutical Sci-Tech DevelopmentLtd (SZSE:301130) Strong Profits May Be Masking Some Underlying Issues

Apr 29
Jilin Province Xidian Pharmaceutical Sci-Tech DevelopmentLtd (SZSE:301130) Strong Profits May Be Masking Some Underlying Issues

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Whilst dividend payments have been stable, 301130 has been paying a dividend for less than 10 years.

Growing Dividend: 301130's dividend payments have increased, but the company has only paid a dividend for 2 years.


Dividend Yield vs Market

Jilin Province Xidian Pharmaceutical Sci-Tech DevelopmentLtd Dividend Yield vs Market
How does 301130 dividend yield compare to the market?
SegmentDividend Yield
Company (301130)1.0%
Market Bottom 25% (CN)0.5%
Market Top 25% (CN)2.1%
Industry Average (Pharmaceuticals)1.7%
Analyst forecast (301130) (up to 3 years)n/a

Notable Dividend: 301130's dividend (0.99%) is higher than the bottom 25% of dividend payers in the CN market (0.53%).

High Dividend: 301130's dividend (0.99%) is low compared to the top 25% of dividend payers in the CN market (2.08%).


Earnings Payout to Shareholders

Earnings Coverage: With its reasonably low payout ratio (47.4%), 301130's dividend payments are well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: 301130 is paying a dividend but the company has no free cash flows.


Discover strong dividend paying companies